Pramod Shivajirao Dhembare

Pramod Shivajirao Dhembare

Active Director Director DIN 01103768
DIN 01103768 First appointment Jan 2007 Primary industry Internet
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 6 active board seats
Past companies 7 historical roles
Total affiliations 13 Since Jan 2007
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 22 Jan 2007
Active appointments 9
Total timeline records 13

Pramod Shivajirao Dhembare (DIN 01103768) has 13 recorded board appointments in Indian companies, the first from January 2007, of which 9 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2007
Fidelity Health Services Private Limited Director · 2024 – present
Current
Mplier Healthcare Ventures Llp Designated Partner · 2024 – present
Current
Mplier Venture Partners Llp Designated Partner · 2021 – present
Current
Creliant Software Private Limited Director · 2017 – present
Current
Creliant Labs Private Limited Director · 2015 – present
Current
Mplier Healthcare Ventures Private Limited Director · 2015 – present
Current
Novo Cellular Medicine Institute Llp Designated Partner · 2015 – present
Current
Bioclin Research Llp Designated Partner · 2015 – present
Current
Fidelity Magbro Life Sciences Llp Designated Partner · 2012 – present
Current
Euman Therapeutics Private Limited Director · 2022 – 2024
Previous
Fidelity Diagnostics Private Limited Director · 2010 – 2025
Previous
Fidelity Life Sciences Private Limited Director · 2010 – 2014
Previous
Synapse Labs Private Limited Director · 2007 – 2014
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available